Dynavax Technologies reported $1.68M in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agenus AGEN:US USD 15.61M 1.88M
Amgen AMGN:US USD 415M 47M
Biogen BIIB:US USD 59.9M 5.9M
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
Bristol Myers Squibb BMY:US USD 294M 5M
Gilead Sciences GILD:US USD 227M 2M
Nektar Therapeutics NKTR:US USD 6.95M 275K
Neurocrine Biosciences NBIX:US USD 1.2M 1000K
Novartis NOVN:VX USD 215M 13M
Pfizer PFE:US USD 313M 2M
Regeneron Pharmaceuticals REGN:US USD 15.3M 2.2M
Roche Holding ROG:VX 256M 90M
Sarepta Therapeutics SRPT:US USD 14.74M 1.29M
Tg Therapeutics TGTX:US USD 1.65M 1.37M
Vertex Pharmaceuticals VRTX:US USD 13.7M 900K